Ticker Details
Zevra Therapeutics, Inc.
IPO Date:	April 13, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$570.09M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 2.47%
Avg Daily Range (30 D):	$0.21 | 2.25%
Avg Daily Range (90 D):	$0.18 | 1.96%

Institutional Daily Volume
Avg Daily Volume:	.59M
Avg Daily Volume (30 D):	1.07M
Avg Daily Volume (90 D):	.84M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	79
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	316
Avg Institutional Trade:	$1.21M
Avg Institutional Trade (30 D):	$.97M
Avg Institutional Trade (90 D):	$1.16M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.23M
Avg Closing Trade (30 D):	$.96M
Avg Closing Trade (90 D):	$.89M
Avg Closing Volume:	142.93K

News

Mar 18, 2026 @ 10:00 AM XOMA Royalty Reports 2025 Financial Results and Hi... Source: Na

Oct 6, 2025 @ 9:51 PM Zevra Therapeutics Announces Inducement Grants und... Source: Nichol Ochsner

Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire

Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A

Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.4	$.2	$1.4
Diluted EPS	$1.35	$.19	$1.35
Revenue	$106.47M	$34.13M	$106.47M
Gross Profit
Net Income / Loss	$83.23M	$12.17M	$83.23M
Operating Income / Loss	$-62.94M	$9.32M	$-62.94M
Cost of Revenue
Net Cash Flow	$28.59M	$8.29M	$28.59M
PE Ratio	6.89

Splits
Dec 28, 2020	1:16